BMRN — Biomarin Pharmaceutical Inc

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

About Biomarin Pharmaceutical Inc

BioMarin Pharmaceutical Inc., a biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally. The company's products include VIMIZIM, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; VOXZOGO, a onc… Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$51.81
Market Cap$10.29B
Float192.2M
Shares Outstanding193.3M
P/E (Forward)10.86
P/E (TTM)38.30
Price/Sales (TTM)3.17
vs. Analyst Target+72.8% to analyst PT
Profit Margin8.29%
Operating Margin (TTM)18.00%
Revenue (TTM)$3.24B
Earnings Growth (YoY)-43.50%
Dividend RateNone
Analyst Target Price$89.54 (29 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 $1.86B $854M $1.34B $83.7M
2021 $1.85B -$64.1M $1.38B $47.4M
2022 $2.10B $142M $1.59B $265M
2023 $2.42B $168M $1.89B $307M
2024 $2.85B $427M $2.27B $651M
2025 $3.22B $349M $2.48B $573M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2025 $825M $241M
Sep 2025 $776M -$30.7M
Dec 2025 $875M -$46.6M
Mar 2026 $766M $106M

Ownership & Float

Insider Ownership0.3%
Institutional Ownership100.6%
Short Float5.6%
% of All Funds Holding6.27%
Number of Funds Holding515

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$54.46Near-term / short-term trend
Weekly40-Week SMA$56.09Medium-term trend
Weekly80-Week SMA$59.36Cyclical trend (business cycle)
Weekly200-Week SMA$77.54Secular trend (multi-year)
Monthly10-Month SMA$56.18Near-term monthly trend
Monthly20-Month SMA$59.96Medium-term monthly trend
Monthly40-Month SMA$73.70Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$63.00 resistance 1.28x 11 months ago
$70.00 resistance 1.25x 12 months ago
$91.00 resistance 1.30x 19 months ago

Historical Earnings Reactions (107 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap 0.00% 0.15% 53.27% 11.99% -24.53%
1 Day 0.79% 0.64% 55.14% 17.64% -31.94%
1 Week 1.54% 0.58% 51.40% 64.47% -28.32%
2 Weeks 0.76% -0.43% 46.73% 92.11% -42.51%
1 Month 2.41% 1.91% 57.94% 54.61% -36.58%

Next earnings: May 7, 2026

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan4.6%63.0%27
Feb1.6%48.1%27
Mar0.2%44.4%27
Apr-2.1%48.1%27
May0.6%50.0%26
Jun1.7%61.5%26
Jul4.0%65.4%26
Aug0.2%55.6%27
Sep-1.2%44.4%27
Oct-2.6%40.7%27
Nov6.1%81.5%27
Dec3.5%63.0%27

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday -0.04% 47.4% 1265
Tuesday 0.02% 48.4% 1383
Wednesday 0.21% 51.4% 1383
Thursday 0.02% 49.0% 1356
Friday 0.13% 50.1% 1352

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 100.6%

Insider Transactions — Smart Summary

Total insider ownership: 0.3%

12-Month Insider Activity Summary

Total Filings5
Net Value-$3.3M
Net Shares Change-39,712
% of Float-0.0%
C-Suite Filings5
Clusters Detected1

Key Insiders

NameTitleNet ValueFilingsActivity
Davis George Eric EVP, Chief Legal Officer -$1.6M 1 1 sell
Guyer Charles Greg EVP, Chief Technical Officer -$996,743.56 1 1 sell
Friberg Gregory R EVP, Chief RandD Officer -$558,619.161 2 2 sell
Burkhart Erin GVP, Chief Accounting Officer -$164,960.58 1 N/A

Transaction Clusters

PeriodFilingsInsidersNet ValueSeniority
2026-02-26 – 2026-03-12 3 3 -$3.0M 3 C-suite

Significant Filings

DateInsiderTitleNet ValuePrice After
2026-05-11 Friberg Gregory R EVP, Chief RandD Officer -$176,681.85 Transaction at $53.85, now -3.8%
2026-02-26 Davis George Eric EVP, Chief Legal Officer -$1.6M Transaction at $61.36, now -15.6%
2026-03-12 Guyer Charles Greg EVP, Chief Technical Officer -$996,743.56 Transaction at $60.46, now -14.3%
2026-02-26 Friberg Gregory R EVP, Chief RandD Officer -$381,937.311 Transaction at $60.38, now -14.2%
2025-05-20 Burkhart Erin GVP, Chief Accounting Officer -$164,960.58 Transaction at $59.29, now -12.6%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Biomarin Pharmaceutical Inc (BMRN) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for BMRN on Trend Edge →